VALIDATION IMAGES
Formalin-fixed and paraffin embedded human colon carcinoma labeled with Anti-ATF3 Polyclonal Antibody, Unconjugated (bs-0519R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Formalin-fixed and paraffin embedded human colon cancer labeled with Anti-ATF3 Polyclonal Antibody, Unconjugated (bs-0519R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Lane 1: mouse lung lysate Lane 2: mouse brain lysate probed with Rabbit Anti-ATF3 Polyclonal Antibody, Unconjugated (bs-0519R) at 1:300 overnight at 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:5000 for 90 min at RT.
Lane 1: Human 293T cell lysates; Lane 2: Human HeLa cell lysates; Lane 3: Human U251 cell lysates; Lane 4: Human A549 cell lysates; Lane 5: Human HepG2 cell lysates probed with ATF1 Polyclonal Antibody, Unconjugated (bs-0519R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
RAW264.7 (M) cells were treated with or without LPS (1ug/ml) for 2 h, 25 μg total protein per lane of cell lysates (see on figure) probed with ATF3 polyclonal antibody, unconjugated (bs-0519R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.
Paraformaldehyde-fixed, paraffin embedded Human Placenta; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with ATF3 Polyclonal Antibody, Unconjugated (bs-0519R) at 1:200 overnight at 4°C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining.